Fenfluramine 163Griffith, J.D., J.G. Nutt, and D.R. Jasinski. “Comparison of Fenfluramine and Amphet-
amine in Man.”Clinical Pharmacology and Therapeutics18 (1975): 563–70.
Gross, S.B. “Appetite Suppressants and Cardiac Valvulopathy. Current Clinical Per-
spectives.”Advance for Nurse Practitioners7 (1999): 36–40.
McCann, U.D., V. Eligulashvili, and G.A. Ricaurte. “Adverse Neuropsychiatric Events
Associated with Dexfenfluramine and Fenfluramine.” Progress in Neuro-
psychopharmacology and Biological Psychiatry22 (1998): 1087–102.
McCann, U.D., et al. “Brain Serotonin Neurotoxicity and Primary Pulmonary Hyper-
tension from Fenfluramine and Dexfenfluramine: Systematic Review of the Ev-
idence.”Journal of the American Medical Association278 (1997): 666–72.
Schiller, N.B. “Fen/Phen and Valvular Heart Disease: If It Sounds Too Bad to Be True,
Perhaps It Isn’t.”Journal of the American College of Cardiology34 (1999): 1159–62.
Vivero, L.E., P.O. Anderson, and R.F. Clark. “A Close Look at Fenfluramine and Dex-
fenfluramine.”Journal of Emergency Medicine16 (1998): 197–205.
Wellman, P.J, and T.J. Maher. “Synergistic Interactions between Fenfluramine and
Phentermine.”International Journal of Obesity and Related Metabolic Disorders 23
(1999): 723–32.